Tag: CBT > Cannabis Schedule: Page 6

Florida

5 Cannabis Policy Reform Efforts to Watch in 2024

From the SAFER Banking Act to state-level reform, Akerman’s Jonathan Robbins outlines the legislation and potential policy changes on the horizon for the industry.

December 27, 2023

Colorado

6 Governors Push Biden to Reschedule Cannabis Before Year’s End

Head executives from Colorado, Illinois, Louisiana, Maryland, New Jersey and New York penned the letter to the White House.

December 6, 2023

Cannabis Rescheduling

US Sen. Kirsten Gillibrand Calls on DEA to Reclassify Cannabis as Schedule III

The New York Democrat says cannabis “is simply not comparable to other Schedule I substances like heroin, LSD and MDMA.”

November 21, 2023

Interviews & Opinion

A Positive Sign For Schedule III

In Vienna, a U.S. state department legal adviser champions member-state discretion over domestic drug policy, potentially removing the obstacle the Single Convention drug treaty could pose to cannabis reform.

November 7, 2023

Cannabis Rescheduling

31 Bipartisan House Lawmakers Urge DEA to End ‘Failed’ Cannabis Prohibition

A group of U.S. representatives sent a letter to DEA Administrator Anne Milgram calling on her agency to “recognize the merits of full descheduling.”

November 1, 2023

Cannabis Rescheduling

‘There Will Be Wind in Our Sails’

September 26, 2023

Cannabis Rescheduling

‘Descheduling Would Not Be Utopia’

Shane Pennington of Porter Wright Morris & Arthur addresses some of the biggest questions and concerns surrounding cannabis rescheduling, including the role of the FDA and Big Pharma.

September 26, 2023

Interviews & Opinion

Opinion: HHS Rescheduling Recommendation is 'About Damn Time'

The U.S. Department of Health and Human Services recognition that cannabis should no longer be classified in the same category as heroin is an event to be celebrated. But the trajectory of U.S. policy deserves to be mourned.

September 20, 2023

Cannabis Industry Research

The Impacts of Cannabis Rescheduling: Panelists Weigh In During International Cannabis Bar Association Webinar

Industry legal experts Khurshid Khoja, Amber Littlejohn and Shane Pennington shared insight into what rescheduling could mean for taxes, research and federal enforcement.

September 12, 2023

Cannabis Rescheduling

‘Rescheduling is Not Enough,’ And Other Reactions to HHS Recommendation on Cannabis

Cannabis industry responds with cautious optimism to the Department of Health and Human Services' call to reschedule the plant, noting the significance of the announcement but also the potential limitations of the move.

September 5, 2023

Cannabis Rescheduling

US Health and Human Services Department Recommends Cannabis Reclassified to Schedule III

The move from Schedule I to Schedule III would provide that cannabis has a federally accepted medical use, but the decision now goes to the DEA.

August 30, 2023

Interviews & Opinion

Opinion: Rescheduling Is Recriminalizing, Descheduling Is Decriminalizing

President of cannabis genetics company DNA Genetics, Rezwan Khan, weighs in on Biden's cannabis policy reform plan and how rescheduling or descheduling the plant would impact the industry.

August 29, 2023